Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × belinostat × 1 year × Clear all

Sponsor

Conditions

Lymphoma, T-Cell, Peripheral 3 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 Uveal Melanoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Mycosis Fungoides 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Eye Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1 Blast Crisis 1

Interventions

fludarabine 18 Whole-Body Irradiation 15 Cyclophosphamide 15 ruxolitinib 14 fludarabine phosphate 12 Tacrolimus 11 Specimen Handling 11 Mycophenolic Acid 11 Biopsy 10 Azacitidine 10 venetoclax 8 Peripheral Blood Stem Cell Transplantation 8 Melphalan 8 Cytarabine 8 Busulfan 7 Injections 6 Stem Cell Transplantation 5 Sirolimus 5 Daunorubicin 5 CPX-351 5 luspatercept 4 itacitinib 4 fedratinib 4 decitabine and cedazuridine drug combination 4 Liposomes 4 Granulocyte Colony-Stimulating Factor 4 ivosidenib 3 Thiotepa 3 Methotrexate 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡